UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

European radiology, 2021-11, Vol.31 (11), p.8692-8702

2021

Volltextzugriff (PDF)

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

The lancet oncology, 2010-08, Vol.11 (8), p.725-732

2010

Volltextzugriff (PDF)

Quality-of-Life Effects of Prostate-Specific Antigen Screening

The New England journal of medicine, 2012-08, Vol.367 (7), p.595-605

2012

Volltextzugriff (PDF)

Prostate cancer: ESMO Consensus Conference Guidelines 2012

Annals of oncology, 2013-05, Vol.24 (5), p.1141-1162

2013

Volltextzugriff (PDF)

How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?

BMJ open, 2024-08, Vol.14 (8), p.e083562

2024

Volltextzugriff (PDF)

Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial

World journal of urology, 2021-09, Vol.39 (9), p.3239-3249

2021

Volltextzugriff (PDF)

Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study

PloS one, 2021-06, Vol.16 (6), p.e0253081-e0253081

2021

Volltextzugriff (PDF)

PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section

International journal of cancer, 2007-01, Vol.120 (1), p.170-174

2007

Volltextzugriff (PDF)

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

BMC medicine, 2008-07, Vol.6 (1), p.19-19, Article 19

2008

Volltextzugriff (PDF)

Prostate cancer grading, time to go back to the future

BJU international, 2021-02, Vol.127 (2), p.165-168

2021

Volltextzugriff (PDF)

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-02, Vol.107 (5), p.2136-2140

2010

Volltextzugriff (PDF)

Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

BMJ Oncology, 2023-04, Vol.2 (1), p.e000039

2023

Volltextzugriff (PDF)

False-positive screening results in the European randomized study of screening for prostate cancer

European journal of cancer (1990), 2011-12, Vol.47 (18), p.2698-2705

2011

Volltextzugriff (PDF)

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

Clinical cancer research, 2010-09, Vol.16 (17), p.4374-4381

2010

Volltextzugriff (PDF)

Agreement between patient reported outcomes and clinical reports after radical prostatectomy - a prospective longitudinal study

BMC urology, 2019-05, Vol.19 (1), p.35-35, Article 35

2019

Volltextzugriff (PDF)

Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinoma

Cancer, 2004-04, Vol.100 (7), p.1397-1405

2004

Volltextzugriff (PDF)

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer

European urology open science (Online), 2021-08, Vol.30, p.25-33

2021

Volltextzugriff (PDF)

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO

European urology open science (Online), 2020-07, Vol.20, p.54-61

2020

Volltextzugriff (PDF)

Post-Radical Prostatectomy Inguinal Hernia: A Simple Surgical Intervention can Substantially Reduce the Incidence—Results From a Prospective Randomized Trial

The Journal of urology, 2010-09, Vol.184 (3), p.984-989

2010

Volltextzugriff (PDF)

Stopping screening, when and how?

Translational andrology and urology, 2018-02, Vol.7 (1), p.46-53

Hugosson, Jonas

2018

Volltextzugriff (PDF)

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study

BMJ (Online), 2014-03, Vol.348 (mar28 1), p.g2296-g2296

2014

Volltextzugriff (PDF)

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

The New England journal of medicine, 2022-12, Vol.387 (23), p.2126-2137

2022

Volltextzugriff (PDF)

Overdetection in screening for prostate cancer

Current opinion in urology, 2014-05, Vol.24 (3), p.256-263

2014

Volltextzugriff (PDF)

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Clinical chemistry (Baltimore, Md.), 2006-02, Vol.52 (2), p.235-239

2006

Volltextzugriff (PDF)

Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

JNCI : Journal of the National Cancer Institute, 2010-07, Vol.102 (13), p.950-958

2010

Volltextzugriff (PDF)

1 – 25 von 286

Suche als RSS-Feed

Aktive Filter

KollektionSAGE Complete

Zeitschrift / SerieEuropean Urology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(250)
Mit Volltextzugriff
(192)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

Quality-of-Life Effects of Prostate-Specific Antigen Screening

Prostate cancer: ESMO Consensus Conference Guidelines 2012

How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?

Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial

Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study

PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

Prostate cancer grading, time to go back to the future

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

False-positive screening results in the European randomized study of screening for prostate cancer

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

Agreement between patient reported outcomes and clinical reports after radical prostatectomy - a prospective longitudinal study

Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinoma

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO

Post-Radical Prostatectomy Inguinal Hernia: A Simple Surgical Intervention can Substantially Reduce the Incidence—Results From a Prospective Randomized Trial

Stopping screening, when and how?

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

Overdetection in screening for prostate cancer

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

Aktive Filter

Suchergebnisse filtern